Global Anhydrous Milk Fat (Butter Oil) Market 2024-2028
Description
Anhydrous Milk Fat (Butter Oil) Market 2024-2028
The anhydrous milk fat (butter oil) market is forecasted to grow by USD 1,573.22 mn during 2023-2028, accelerating at a CAGR of 7.51% during the forecast period. The report on the anhydrous milk fat (butter oil) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising consumer demand for premium and specialty products, increasing demand for anhydrous milk fat (butter oil) due to growth in food processing industry, and long shelf life and versatility of anhydrous milk fat (butter oil).
Technavio's anhydrous milk fat (butter oil) market is segmented as below:
By Distribution Channel
- Offline
- Online
- Conventional
- Organic
- APAC
- Europe
- North America
- South America
- Middle East and Africa
The report on the anhydrous milk fat (butter oil) market covers the following areas:
- Anhydrous milk fat (butter oil) market sizing
- Anhydrous milk fat (butter oil) market forecast
- Anhydrous milk fat (butter oil) market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Table of Contents
149 Pages
- 1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
- Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary - Chart on Incremental Growth
- Exhibit 08: Executive Summary - Data Table on Incremental Growth
- Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
- 2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
- 3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- 4 Historic Market Size
- 4.1 Global tardive dyskinesia treatment market 2018 - 2022
- Exhibit 18: Historic Market Size - Data Table on global tardive dyskinesia treatment market 2018 - 2022 ($ million)
- 4.2 End-user Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
- 4.3 Product Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
- 5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
- 6 Market Segmentation by End-user
- 6.1 Market segments
- Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
- 6.2 Comparison by End-user
- Exhibit 32: Chart on Comparison by End-user
- Exhibit 33: Data Table on Comparison by End-user
- 6.3 Hospital pharmacy - Market size and forecast 2023-2028
- Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- 6.4 Retail pharmacy - Market size and forecast 2023-2028
- Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- 6.5 Online pharmacy - Market size and forecast 2023-2028
- Exhibit 42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by End-user
- Exhibit 46: Market opportunity by End-user ($ million)
- Exhibit 47: Data Table on Market opportunity by End-user ($ million)
- 7 Market Segmentation by Product
- 7.1 Market segments
- Exhibit 48: Chart on Product - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
- 7.2 Comparison by Product
- Exhibit 50: Chart on Comparison by Product
- Exhibit 51: Data Table on Comparison by Product
- 7.3 Austedo and Ingrezza - Market size and forecast 2023-2028
- Exhibit 52: Chart on Austedo and Ingrezza - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Austedo and Ingrezza - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Austedo and Ingrezza - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Austedo and Ingrezza - Year-over-year growth 2023-2028 (%)
- 7.4 Amantadine and others - Market size and forecast 2023-2028
- Exhibit 56: Chart on Amantadine and others - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Amantadine and others - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Amantadine and others - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Amantadine and others - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Product
- Exhibit 60: Market opportunity by Product ($ million)
- Exhibit 61: Data Table on Market opportunity by Product ($ million)
- 8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 UK - Market size and forecast 2023-2028
- Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.10 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.11 France - Market size and forecast 2023-2028
- Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Exhibit 103: Market opportunity By Geographical Landscape ($ million)
- Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
- 10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028
- 10.4 Market trends
- 11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 108: Impact of key risks on business
- 12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 109: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification
- 12.3 Abbott Laboratories
- Exhibit 111: Abbott Laboratories - Overview
- Exhibit 112: Abbott Laboratories - Business segments
- Exhibit 113: Abbott Laboratories - Key news
- Exhibit 114: Abbott Laboratories - Key offerings
- Exhibit 115: Abbott Laboratories - Segment focus
- 12.4 Alembic Pharmaceuticals Ltd.
- Exhibit 116: Alembic Pharmaceuticals Ltd. - Overview
- Exhibit 117: Alembic Pharmaceuticals Ltd. - Product / Service
- Exhibit 118: Alembic Pharmaceuticals Ltd. - Key offerings
- 12.5 Aspire Pharma Ltd.
- Exhibit 119: Aspire Pharma Ltd. - Overview
- Exhibit 120: Aspire Pharma Ltd. - Product / Service
- Exhibit 121: Aspire Pharma Ltd. - Key offerings
- 12.6 Centaur Pharmaceuticals Pvt. Ltd.
- Exhibit 122: Centaur Pharmaceuticals Pvt. Ltd. - Overview
- Exhibit 123: Centaur Pharmaceuticals Pvt. Ltd. - Product / Service
- Exhibit 124: Centaur Pharmaceuticals Pvt. Ltd. - Key offerings
- 12.7 Cipla Ltd.
- Exhibit 125: Cipla Ltd. - Overview
- Exhibit 126: Cipla Ltd. - Business segments
- Exhibit 127: Cipla Ltd. - Key news
- Exhibit 128: Cipla Ltd. - Key offerings
- Exhibit 129: Cipla Ltd. - Segment focus
- 12.8 Lannett Co. Inc.
- Exhibit 130: Lannett Co. Inc. - Overview
- Exhibit 131: Lannett Co. Inc. - Product / Service
- Exhibit 132: Lannett Co. Inc. - Key offerings
- 12.9 Luye Pharma Group Ltd.
- Exhibit 133: Luye Pharma Group Ltd. - Overview
- Exhibit 134: Luye Pharma Group Ltd. - Business segments
- Exhibit 135: Luye Pharma Group Ltd. - Key offerings
- Exhibit 136: Luye Pharma Group Ltd. - Segment focus
- 12.10 Neurocrine Biosciences Inc.
- Exhibit 137: Neurocrine Biosciences Inc. - Overview
- Exhibit 138: Neurocrine Biosciences Inc. - Product / Service
- Exhibit 139: Neurocrine Biosciences Inc. - Key offerings
- 12.11 Novartis AG
- Exhibit 140: Novartis AG - Overview
- Exhibit 141: Novartis AG - Business segments
- Exhibit 142: Novartis AG - Key offerings
- Exhibit 143: Novartis AG - Segment focus
- 12.12 Psicofarma S. A. de C. V
- Exhibit 144: Psicofarma S. A. de C. V - Overview
- Exhibit 145: Psicofarma S. A. de C. V - Product / Service
- Exhibit 146: Psicofarma S. A. de C. V - Key offerings
- 12.13 Sawai Group Holdings Co. Ltd.
- Exhibit 147: Sawai Group Holdings Co. Ltd. - Overview
- Exhibit 148: Sawai Group Holdings Co. Ltd. - Product / Service
- Exhibit 149: Sawai Group Holdings Co. Ltd. - Key offerings
- 12.14 SOM Innovation Biotech S.A.
- Exhibit 150: SOM Innovation Biotech S.A. - Overview
- Exhibit 151: SOM Innovation Biotech S.A. - Product / Service
- Exhibit 152: SOM Innovation Biotech S.A. - Key offerings
- 12.15 SteriMax Inc.
- Exhibit 153: SteriMax Inc. - Overview
- Exhibit 154: SteriMax Inc. - Product / Service
- Exhibit 155: SteriMax Inc. - Key offerings
- 12.16 Sun Pharmaceutical Industries Ltd.
- Exhibit 156: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 157: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 158: Sun Pharmaceutical Industries Ltd. - Key offerings
- 12.17 Teva Pharmaceutical Industries Ltd.
- Exhibit 159: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 160: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 163: Teva Pharmaceutical Industries Ltd. - Segment focus
- 13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 164: Inclusions checklist
- Exhibit 165: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 166: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 167: Research methodology
- Exhibit 168: Validation techniques employed for market sizing
- Exhibit 169: Information sources
- 13.5 List of abbreviations
- Exhibit 170: List of abbreviations
- Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
- Exhibits6: Executive Summary - Chart on Market Segmentation by Product
- Exhibits7: Executive Summary - Chart on Incremental Growth
- Exhibits8: Executive Summary - Data Table on Incremental Growth
- Exhibits9: Executive Summary - Chart on Vendor Market Positioning
- Exhibits10: Parent market
- Exhibits11: Market Characteristics
- Exhibits12: Offerings of vendors included in the market definition
- Exhibits13: Market segments
- Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits18: Historic Market Size - Data Table on global tardive dyskinesia treatment market 2018 - 2022 ($ million)
- Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
- Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
- Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
- Exhibits23: Five forces analysis - Comparison between 2023 and 2028
- Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
- Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
- Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
- Exhibits29: Chart on Market condition - Five forces 2023 and 2028
- Exhibits30: Chart on End-user - Market share 2023-2028 (%)
- Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
- Exhibits32: Chart on Comparison by End-user
- Exhibits33: Data Table on Comparison by End-user
- Exhibits34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibits35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibits36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibits37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibits38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibits39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibits40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibits41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibits42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibits43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibits44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibits45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibits46: Market opportunity by End-user ($ million)
- Exhibits47: Data Table on Market opportunity by End-user ($ million)
- Exhibits48: Chart on Product - Market share 2023-2028 (%)
- Exhibits49: Data Table on Product - Market share 2023-2028 (%)
- Exhibits50: Chart on Comparison by Product
- Exhibits51: Data Table on Comparison by Product
- Exhibits52: Chart on Austedo and Ingrezza - Market size and forecast 2023-2028 ($ million)
- Exhibits53: Data Table on Austedo and Ingrezza - Market size and forecast 2023-2028 ($ million)
- Exhibits54: Chart on Austedo and Ingrezza - Year-over-year growth 2023-2028 (%)
- Exhibits55: Data Table on Austedo and Ingrezza - Year-over-year growth 2023-2028 (%)
- Exhibits56: Chart on Amantadine and others - Market size and forecast 2023-2028 ($ million)
- Exhibits57: Data Table on Amantadine and others - Market size and forecast 2023-2028 ($ million)
- Exhibits58: Chart on Amantadine and others - Year-over-year growth 2023-2028 (%)
- Exhibits59: Data Table on Amantadine and others - Year-over-year growth 2023-2028 (%)
- Exhibits60: Market opportunity by Product ($ million)
- Exhibits61: Data Table on Market opportunity by Product ($ million)
- Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits65: Chart on Geographic comparison
- Exhibits66: Data Table on Geographic comparison
- Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
- Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
- Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
- Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
- Exhibits99: Chart on France - Market size and forecast 2023-2028 ($ million)
- Exhibits100: Data Table on France - Market size and forecast 2023-2028 ($ million)
- Exhibits101: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibits102: Data Table on France - Year-over-year growth 2023-2028 (%)
- Exhibits103: Market opportunity By Geographical Landscape ($ million)
- Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
- Exhibits105: Impact of drivers and challenges in 2023 and 2028
- Exhibits106: Overview on Criticality of inputs and Factors of differentiation
- Exhibits107: Overview on factors of disruption
- Exhibits108: Impact of key risks on business
- Exhibits109: Vendors covered
- Exhibits110: Matrix on vendor position and classification
- Exhibits111: Abbott Laboratories - Overview
- Exhibits112: Abbott Laboratories - Business segments
- Exhibits113: Abbott Laboratories - Key news
- Exhibits114: Abbott Laboratories - Key offerings
- Exhibits115: Abbott Laboratories - Segment focus
- Exhibits116: Alembic Pharmaceuticals Ltd. - Overview
- Exhibits117: Alembic Pharmaceuticals Ltd. - Product / Service
- Exhibits118: Alembic Pharmaceuticals Ltd. - Key offerings
- Exhibits119: Aspire Pharma Ltd. - Overview
- Exhibits120: Aspire Pharma Ltd. - Product / Service
- Exhibits121: Aspire Pharma Ltd. - Key offerings
- Exhibits122: Centaur Pharmaceuticals Pvt. Ltd. - Overview
- Exhibits123: Centaur Pharmaceuticals Pvt. Ltd. - Product / Service
- Exhibits124: Centaur Pharmaceuticals Pvt. Ltd. - Key offerings
- Exhibits125: Cipla Ltd. - Overview
- Exhibits126: Cipla Ltd. - Business segments
- Exhibits127: Cipla Ltd. - Key news
- Exhibits128: Cipla Ltd. - Key offerings
- Exhibits129: Cipla Ltd. - Segment focus
- Exhibits130: Lannett Co. Inc. - Overview
- Exhibits131: Lannett Co. Inc. - Product / Service
- Exhibits132: Lannett Co. Inc. - Key offerings
- Exhibits133: Luye Pharma Group Ltd. - Overview
- Exhibits134: Luye Pharma Group Ltd. - Business segments
- Exhibits135: Luye Pharma Group Ltd. - Key offerings
- Exhibits136: Luye Pharma Group Ltd. - Segment focus
- Exhibits137: Neurocrine Biosciences Inc. - Overview
- Exhibits138: Neurocrine Biosciences Inc. - Product / Service
- Exhibits139: Neurocrine Biosciences Inc. - Key offerings
- Exhibits140: Novartis AG - Overview
- Exhibits141: Novartis AG - Business segments
- Exhibits142: Novartis AG - Key offerings
- Exhibits143: Novartis AG - Segment focus
- Exhibits144: Psicofarma S. A. de C. V - Overview
- Exhibits145: Psicofarma S. A. de C. V - Product / Service
- Exhibits146: Psicofarma S. A. de C. V - Key offerings
- Exhibits147: Sawai Group Holdings Co. Ltd. - Overview
- Exhibits148: Sawai Group Holdings Co. Ltd. - Product / Service
- Exhibits149: Sawai Group Holdings Co. Ltd. - Key offerings
- Exhibits150: SOM Innovation Biotech S.A. - Overview
- Exhibits151: SOM Innovation Biotech S.A. - Product / Service
- Exhibits152: SOM Innovation Biotech S.A. - Key offerings
- Exhibits153: SteriMax Inc. - Overview
- Exhibits154: SteriMax Inc. - Product / Service
- Exhibits155: SteriMax Inc. - Key offerings
- Exhibits156: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibits157: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibits158: Sun Pharmaceutical Industries Ltd. - Key offerings
- Exhibits159: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibits160: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibits161: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibits162: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibits163: Teva Pharmaceutical Industries Ltd. - Segment focus
- Exhibits164: Inclusions checklist
- Exhibits165: Exclusions checklist
- Exhibits166: Currency conversion rates for US$
- Exhibits167: Research methodology
- Exhibits168: Validation techniques employed for market sizing
- Exhibits169: Information sources
- Exhibits170: List of abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
